SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical and Applied Thrombosis/Hemostasis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zerbinati, P.
Right arrow Articles by Girolami, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zerbinati, P.
Right arrow Articles by Girolami, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Two Methods for Intraplatelet Serotonin Evaluation: Their Use in Thrombocytosis

Patrizia Zerbinati, Ph.D.

Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy

Maria Luigia Randi, M.D.

Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy

Carla Rossi, M.D.

Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy

Barbara Soini, M.D.

Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy

Antonio Girolami, M.D.

Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy

The content of platelet dense bodies is considered to be decreased in thrombocytosis associated myeloproliferative disorders and normal in reactive thrombocytosis. Intraplatelet serotonin i.e., 5-hydroxytryptamine (5HT), content is usually considered a particularly good marker. We report our experience of platelet 5HT levels evaluated by radioimmunoassay (RIA) and fluorimetric assays in patients with high platelet counts due to essential thrombocythemia (48 patients) or reactive thrombocytosis (34 patients). The diagnosis of essential thrombocythemia was made according to Polycythemia Vera Study Group criteria. A significant statistical difference was observed in serotonin platelet content between essential thrombocythemia and secondary thrombocytosis patients both with fluorimetric and RIA assays. On the contrary, no difference was evident between reactive thrombocytosis patients and normal control subjects. However, a significant difference was observed between 5HT in serum and platelet pellets when evaluated by RIA. Statistical analysis with the X2 test showed that the sensitivity of the fluorimetric assay is slightly higher than that of the RIA assay; however, specificity is about the same with the two methods. It is possible that the two assays measure different molecules. At any rate, the fluorimetric assay seems to be better in evaluating the platelet content of 5HT at least in patients with high platelet counts. Key Words: Thrombocytosis—Serotonin.

Clinical and Applied Thrombosis/Hemostasis, Vol. 3, No. 2, 144-146 (1997)
DOI: 10.1177/107602969700300215


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement